Health Care: Drugs

Halozyme Therapeutics Inc (HALO: NASDAQ)

$9.4 n/a | n/a%
10/21/16 - 04:00 PM ET
Growth Rates

Growth Rates data is not available for HALO.

Portfolios with HALO

Latest HALO Headlines from TheStreet

More Financial News for HALO

Press Releases for HALO

See All Press Releases

Partner Headlines for HALO

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter